nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Loperamide—POMC—adrenal gland cancer	0.0975	0.603	CrCbGaD
Darifenacin—Fexofenadine—ABCB1—adrenal gland cancer	0.0183	0.113	CrCbGaD
Darifenacin—Clotrimazole—ABCB1—adrenal gland cancer	0.0141	0.0872	CrCbGaD
Darifenacin—Fentanyl—ABCB1—adrenal gland cancer	0.0121	0.0745	CrCbGaD
Darifenacin—Loperamide—ABCB1—adrenal gland cancer	0.0116	0.0718	CrCbGaD
Darifenacin—Methadone—ABCB1—adrenal gland cancer	0.00827	0.0511	CrCbGaD
Darifenacin—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00419	0.005	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00416	0.00496	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00415	0.00495	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00411	0.0049	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00409	0.00488	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00407	0.00486	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00404	0.00481	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00403	0.0048	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00402	0.0048	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00401	0.00478	CbGpPWpGaD
Darifenacin—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00391	0.00466	CbGpPWpGaD
Darifenacin—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00389	0.00465	CbGpPWpGaD
Darifenacin—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00386	0.0046	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00385	0.0046	CbGpPWpGaD
Darifenacin—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00385	0.0046	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00371	0.00442	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0037	0.00441	CbGpPWpGaD
Darifenacin—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00369	0.0044	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00366	0.00437	CbGpPWpGaD
Darifenacin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00325	0.00387	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00317	0.00378	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00316	0.00377	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00313	0.00373	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00299	0.00357	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00298	0.00355	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00295	0.00352	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00282	0.00337	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00281	0.00336	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00279	0.00333	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00271	0.00324	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00271	0.00323	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00271	0.00323	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00268	0.0032	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00268	0.00319	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00266	0.00317	CbGpPWpGaD
Darifenacin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00263	0.00314	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0026	0.0031	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00259	0.00309	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00256	0.00306	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00254	0.00303	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00244	0.00291	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00241	0.00288	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00238	0.00284	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00237	0.00282	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00233	0.00278	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00231	0.00275	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00228	0.00272	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00227	0.0027	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00221	0.00264	CbGpPWpGaD
Darifenacin—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00221	0.00263	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00215	0.00257	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00215	0.00256	CbGpPWpGaD
Darifenacin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00212	0.00253	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00212	0.00253	CbGpPWpGaD
Darifenacin—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00211	0.00252	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00209	0.00249	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00208	0.00248	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00206	0.00246	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00206	0.00246	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00199	0.00237	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0018	0.00215	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00179	0.00214	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00179	0.00213	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00178	0.00213	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00177	0.00211	CbGpPWpGaD
Darifenacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00172	0.00205	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00164	0.00196	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00164	0.00196	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00164	0.00195	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00163	0.00194	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00162	0.00193	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00162	0.00193	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0016	0.00191	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.0016	0.00191	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0016	0.00191	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0016	0.0019	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00159	0.0019	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00158	0.00189	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00158	0.00188	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00158	0.00188	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00157	0.00187	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00154	0.00184	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00149	0.00178	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00149	0.00177	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00149	0.00177	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00148	0.00177	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00148	0.00176	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00147	0.00176	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00147	0.00175	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00145	0.00173	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00145	0.00173	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00145	0.00173	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00144	0.00172	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00144	0.00172	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00143	0.00171	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00143	0.00171	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00142	0.0017	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0014	0.00167	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.0014	0.00167	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0014	0.00167	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00138	0.00165	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00138	0.00165	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00138	0.00164	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00136	0.00163	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00135	0.00161	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00135	0.00161	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00132	0.00157	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00131	0.00156	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.0013	0.00155	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00127	0.00151	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00125	0.00149	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00125	0.00149	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00125	0.00149	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00125	0.00149	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00122	0.00145	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.0012	0.00143	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00119	0.00142	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00114	0.00136	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00111	0.00132	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00111	0.00132	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00111	0.00132	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.0011	0.00132	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00109	0.0013	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00104	0.00124	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00104	0.00124	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00103	0.00122	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MED12—adrenal gland cancer	0.001	0.0012	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000983	0.00117	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000971	0.00116	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000968	0.00116	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00096	0.00115	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000959	0.00114	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000957	0.00114	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000948	0.00113	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000928	0.00111	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000927	0.00111	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000925	0.0011	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000916	0.00109	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000914	0.00109	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000911	0.00109	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000888	0.00106	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000882	0.00105	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000879	0.00105	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000878	0.00105	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000876	0.00104	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000873	0.00104	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000871	0.00104	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000867	0.00103	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000856	0.00102	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000853	0.00102	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000845	0.00101	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000843	0.00101	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.000842	0.001	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00084	0.001	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000832	0.000993	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000817	0.000975	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.000806	0.000962	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000805	0.000961	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000805	0.000961	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000805	0.00096	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000802	0.000957	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000795	0.000948	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.000773	0.000922	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000745	0.000889	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.00074	0.000883	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000739	0.000881	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000732	0.000874	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.00072	0.000859	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000713	0.000851	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.000707	0.000844	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00069	0.000823	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000625	0.000746	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000623	0.000743	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.00062	0.00074	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000617	0.000736	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000614	0.000733	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000612	0.000731	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000606	0.000724	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.0006	0.000716	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000594	0.000708	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000594	0.000708	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000583	0.000695	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000568	0.000677	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000566	0.000675	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.00056	0.000668	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000539	0.000643	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000526	0.000628	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000526	0.000628	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000521	0.000622	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000519	0.00062	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000517	0.000616	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000514	0.000614	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000502	0.000599	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000501	0.000597	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000498	0.000594	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000497	0.000593	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000496	0.000592	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000496	0.000592	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000492	0.000586	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000491	0.000586	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000486	0.000579	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000484	0.000578	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000479	0.000572	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000476	0.000568	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000476	0.000568	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.00047	0.000561	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000456	0.000544	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000438	0.000522	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000418	0.000499	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000417	0.000497	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000413	0.000492	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—adrenal gland cancer	0.0004	0.000477	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000392	0.000468	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000364	0.000434	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000363	0.000433	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000359	0.000428	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000355	0.000423	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000355	0.000423	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000348	0.000416	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00034	0.000405	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000335	0.0004	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000334	0.000399	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000331	0.000395	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000331	0.000395	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.00033	0.000394	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000327	0.00039	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000321	0.000383	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.00032	0.000382	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000319	0.00038	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000317	0.000378	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000286	0.000342	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000281	0.000335	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000269	0.000321	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000239	0.000285	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000239	0.000285	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000239	0.000285	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000236	0.000282	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000236	0.000282	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000232	0.000277	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000228	0.000272	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000226	0.00027	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000191	0.000227	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.00019	0.000226	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000189	0.000225	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000187	0.000223	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000159	0.00019	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000159	0.000189	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000157	0.000187	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000156	0.000186	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000125	0.000149	CbGpPWpGaD
